2013
DOI: 10.1016/j.jmgm.2012.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Replica exchange molecular dynamics simulation of chitosan for drug delivery system based on carbon nanotube

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
22
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 38 publications
(23 citation statements)
references
References 74 publications
0
22
0
1
Order By: Relevance
“…The AMBER12 simulation package was employed for the molecular dynamics simulations [50], which had been successfully carried out in the study of the carbon nanotubes [51][52][53][54][55]. All calculations were performed in the isothermal-isobaric ensemble at 1 atm and 300 K using the SANDER module in the AMBER 12 program.…”
Section: Molecular Dynamic Simulationsmentioning
confidence: 99%
“…The AMBER12 simulation package was employed for the molecular dynamics simulations [50], which had been successfully carried out in the study of the carbon nanotubes [51][52][53][54][55]. All calculations were performed in the isothermal-isobaric ensemble at 1 atm and 300 K using the SANDER module in the AMBER 12 program.…”
Section: Molecular Dynamic Simulationsmentioning
confidence: 99%
“…42,43 Such calculations could encourage researchers in manufacturing new drug delivery systems. 7,44 In spite of different theoretical studies on CNTs, so far few studies have been performed on the mechanism of functionalization.…”
Section: Introductionmentioning
confidence: 99%
“…Previous computational modeling predicted that when CS was helically wrapped on CNT and acted as a linker between the EGF and SWCNT to form a targeted DDS, the CS covering was long enough to cover the SWCNT surface with enough residual flexible chain to avoid steric hindrance between the binding region of the EGF and its receptor (Rungnim, Rungrotmongkol, Hannongbua, & Okumura, 2013). Both theoretical and experimental works (Burgess et al, 2003;Dawson et al, 2005;Ferguson et al, 2003) have shown a high binding affinity of EGF towards the EGFR, while a kinetic study of the EGF-EGFR interaction suggested that EGF can bind with either an inactive expanded EGFR dimer or a tethered EGFR monomer before inducing the EGFR dimerization process (Björkelund, Gedda, Malmqvist, & Andersson, 2013;Lemmon, 2009 in vitro and in vivo studies on the use of EGF as targeting agent in DDS applications (Bhirde, et al, 2009;Cheng et al, 2012;Shevtsov et al, 2014;Tseng et al, 2008;Yang et al, 2009).…”
Section: Introductionmentioning
confidence: 99%